Financial Instruments and Contingent Consideration (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Estimated Fair Value of Financial Instruments

The estimated fair values of our financial instruments are as follows: 

	March 31, 2021						December 31, 2020
	Carrying amount			Estimated fair value			Carrying amount			Estimated fair value
(Liabilities), net:
Total long-term debt, including current portion	$	(709.4	)	$	(703.4	)	$	(715.5	)	$	(715.5	)
Interest rate swap contracts		(24.2	)		(24.2	)		(28.9	)		(28.9	)
Acquisition-related contingent consideration		(17.1	)		(17.1	)		(16.9	)		(16.9	)

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The fair value measurement of liabilities measured at fair value on a recurring basis and reported on the Condensed Consolidated Balance Sheets is summarized below:

	March 31, 2021						December 31, 2020
	Fair value based on						Fair value based on
	Other observable inputs			Other unobservable inputs			Other observable inputs			Other unobservable inputs
	Level 2			Level 3			Level 2			Level 3
(Liabilities), net:
Interest rate swap contracts	$	(24.2	)	$	-		$	(28.9	)	$	-
Acquisition-related contingent consideration		-			(17.1	)		-			(16.9	)

Schedule of Weighted-average Of Significant Unobservable Inputs

The following table summarizes the weighted average of the significant unobservable inputs as of March 31, 2021:

	Moz			Turf
Unobservable input
Volatility		23.9	%		24.3	%
Discount rates		2.8	%		2.8	%

Schedule of Changes in Fair Value of the Acquisition-related Contingent Consideration Liability

The changes in fair value of the acquisition-related contingent consideration liability for the three months ended March 31, 2021 were as follows:

	Three Months Ended
	March 31, 2021
Balance as of beginning of period	$	16.9
Adjustments to fair value measurements		0.2
Balance as of end of period	$	17.1